Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 11086024.
- Also identified by PMC identifier 381439.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Estrogen deficiency induces bone loss by upregulating osteoclastogenesis by mechanisms not completely defined. We found that ovariectomy-enhanced T-cell production of TNF-alpha, which, acting through the TNF-alpha receptor p55, augments macrophage colony-stimulating factor-induced (M-CSF-induced) and RANKL-induced osteoclastogenesis. Ovariectomy failed to induce bone loss, stimulate bone resorption, or increase M-CSF- and RANKL-dependent osteoclastogenesis in T-cell deficient mice, establishing T cells as essential mediators of the bone-wasting effects of estrogen deficiency in vivo. These findings demonstrate that the ability of estrogen to target T cells, suppressing their production of TNF-alpha, is a key mechanism by which estrogen prevents osteoclastic bone resorption and bone loss.
Medical subject headings
- Antigens, CD
- Bone Resorption
- Carrier Proteins
- Estrogens
- Membrane Glycoproteins
- Receptors, Tumor Necrosis Factor
- T-Lymphocytes
- Tumor Necrosis Factor-alpha